다계통위축증 환자를 대상으로 한 마비말장애 집중 치료의 효과
Efficacy of intensive treatment of dysarthria for people with multiple system atrophy
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
A mixed dysarthria with combinations of hypokinetic, ataxic, and spastic components is a common clinical feature of multiple system atrophy (MSA). Due to the rapid progress of dysarthria after diagnosis, people with MSA experience difficulty with verbal communication, which eventually affects their quality of life negatively. In this study, SPEAK OUT!Ⓡ, an intensive 1:1 treatment of dysarthria for improving functional communicative ability, was provided to twelve people with MSA. To evaluate the efficacy of SPEAK OUT!Ⓡ in people with MSA, aerodynamic, acoustic, and perceptual analyses were conducted. Pre-and post-therapy data included maximum phonation time, vocal intensity, and fundamental frequency during /a/ sustained phonation and passage reading; frequency range between high /a/ and low /a/ phonation; jitter, shimmer, and HNR for vocal quality; speech rate during passage reading; and perceptual evaluation scores for articulation precision and intonation. The participants achieved statistically significant improvement in vocal intensity, pitch range, vocal quality, speech rate, and speech intelligibility. In conclusion, SPEAK OUT!Ⓡ is a feasible treatment for people with MSA to efficaciously improve their speech ability.
Abstract
A mixed dysarthria with combinations of hypokinetic, ataxic, and spastic components is a common clinical feature of multiple system atrophy (MSA). Due to the rapid progress of dysarthria after diagnosis, people with MSA experience difficulty with verbal communication, which eventually affects their quality of life negatively. In this study, SPEAK OUT!Ⓡ, an intensive 1:1 treatment of dysarthria for improving functional communicative ability, was provided to twelve people with MSA. To evaluate the efficacy of SPEAK OUT!Ⓡ in people with MSA, aerodynamic, acoustic, and perceptual analyses were conducted. Pre-and post-therapy data included maximum phonation time, vocal intensity, and fundamental frequency during /a/ sustained phonation and passage reading; frequency range between high /a/ and low /a/ phonation; jitter, shimmer, and HNR for vocal quality; speech rate during passage reading; and perceptual evaluation scores for articulation precision and intonation. The participants achieved statistically significant improvement in vocal intensity, pitch range, vocal quality, speech rate, and speech intelligibility. In conclusion, SPEAK OUT!Ⓡ is a feasible treatment for people with MSA to efficaciously improve their speech ability.
참고문헌 (22)
- Albanese, A., "Multiple system atrophy presenting as parkinsonism: Clinical features and diagnostic criteria", Journal of Neurology, Neurosurgery, and Psychiatry, 59(2), pp.144~151 (1995)
- Baken, R. J., "Clinical measurement of speech and voice" (2000), Singular
- Ben-Shlomo, Y., "Survival of patients with pathologically proven multiple system atrophy: A meta-analysis", Neurology, 48(2), pp.384~393 (1997)
- Boutsen, F., "Prosodic improvement in persons with parkinson disease receiving SPEAK OUT!® voice therapy", Folia Phoniatrica et Logopaedica, 70(2), pp.51~58 (2018)
- Countryman, S., "Speech and voice deficits in parkinsonian plus syndromes: Can they be treated?", NCVS Status and Progress Report, 6(5), pp.99~111 (1994)
- Duffy, J. R., "Motor speech disorders. Substrates, differential diagnosis and management" (2005), Mosby
- Flabeau, O., "Multiple system atrophy: Current and future approaches to management", Therapeutic Advances in Neurological Disorders, 3(4), pp.249~263 (2010)
- Freed, D. B., "Motor speech disorders: Diagnosis and treatment" (2018), Plural Publishing
- Hartelius, L., "Perceptual analysis of speech in multiple system atrophy and progressive supranuclear palsy", Journal of Medical Speech anguage Pathology, 14(4), pp.241~247 (2006)
- Kim, Y., "Perceptual and acoustical features of dysarthria in multiple system atrophy", Journal of Medical Speech-Language Pathology, 18(4), pp.66~70 (2010)
- Kluin, K. J., "Characteristics of the dysarthria of multiple system atrophy", Archives of Neurology, 53, pp.545~548 (1996)
- Levin, J., "The differential diagnosis and treatment of atypical parkinsonism", Deutsches Ӓrzteblatt International, 113, pp.61~69 (2016)
- Levitt, J. S., "Case study: The effects of the “SPEAK OUT! ®” voice program for Parkinson’s disease", International Journal of Applied Science and Technology, 4(2), pp.20~28 (2014)
- 박영미, "집중치료를 통한 소뇌운동실조증 환자의 말운동개선 가능성", 한국콘텐츠학회 논문지, 18(11), pp.634~642 (2018), 한국콘텐츠학회[DOI]
- "Parkinson’s information session" (2018)[URL]
- Pezzoli, G., "An overview of parkinsonian syndromes: Data from the literature and from an Italian data-base", Sleep Medicine, 5(2), pp.181~187 (2004)
- Quinn, N., "Multiple system atrophy-the nature of the beast", Journal of Neurology, Neurosurgery, and Psychiatry, 78(Suppl), pp.78~89 (1989)
- Schrag, A., "Prevalence of progressive supranuclear palsy and multiple system atrophy: A cross-sectional study", Lancet, 354(9192), pp.1771~1775 (1999)
- Stefanova, N., "Multiple system atrophy: An update", The Lancet Neurology, 8(12), pp.1172~1178 (2009)
- Watts, C. R., "A retrospective study of long-term treatment outcomes for reduced vocal intensity in hypokinetic dysarthria", BMC Ear Nose Throat Disorders, 16(2), pp.1~7 (2016)
- Wenning, G. K., "Recent development in multiple system atrophy", Journal of Neurology, 256, pp.1791~1808 (2009)
- Wenning, G. K., "Multiple system atrophy", The Lancet Neurology, 3(2), pp.93~103 (2004)